EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Development of the Japanese version of the Challenging Experience Questionnaire

Hideaki Tani, Kengo Yonezawa, Keisuke Kusudo, Frederick S Barrett, Shinichiro Nakajima iD, Hiroyuki Uchida iD

Neuropsychopharmacology Reports · 2024

DOI: 10.1002/npr2.12456 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuropsychopharmacology Reports, 2024. Verfasst von Hideaki Tani und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan. Hauptthemen laut MEDLINE: Hallucinogens. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The therapeutic potential of psychedelics for various mental disorders has gained significant interest. Previous studies have highlighted that psychedelics induce psychoactive effects, including challenging aspects of experiences. These experiences are assessed using the Challenging Experience Questionnaire (CEQ), yet its Japanese version has been unavailable. This study aimed to create a Japanese version of the CEQ.

Methods

We followed the “Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient‐Reported Outcomes (PRO) Measures: Report of the ISPOR Task Force for Translation and Cultural Adaptation.” Initially, two Japanese psychiatrists independently conducted the forward translations. These were then reconciled into a single version, which was back‐translated into English. The original authors reviewed this back‐translation for accuracy, leading to revisions through continuous dialogue until the original authors approved the final version.

Results

The final, approved back‐translated version of the CEQ is presented in the figure.

Conclusions

This study developed a Japanese version of the CEQ, enabling the assessment of challenging experiences during psychedelic‐assisted therapy for Japanese speakers. Further studies are needed to assess the reliability and validity of this newly translated version.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HallucinogensAdultFemaleHumansMaleJapanPatient Reported Outcome MeasuresReproducibility of ResultsSurveys and QuestionnairesTranslations

Stichwörter der Autor:innen

Challenging Experience Questionnairehumanpsychedelics

Substanzen

Hallucinogens

Autor:innen und Institutionen

  • Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.
  • Center for Psychedelic and Consciousness Research, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

ORCID-Profile: Shinichiro Nakajima, Hiroyuki Uchida

Förderung

  • Japan Agency for Medical Research and Development

Zitieren

APA

Tani, H., Yonezawa, K., Kusudo, K., Barrett, F. S., Nakajima, S., & Uchida, H. (2024). Development of the Japanese version of the Challenging Experience Questionnaire. Neuropsychopharmacology Reports. https://doi.org/10.1002/npr2.12456

Vancouver

Tani H, Yonezawa K, Kusudo K, Barrett FS, Nakajima S, Uchida H. Development of the Japanese version of the Challenging Experience Questionnaire. Neuropsychopharmacology Reports. 2024. doi:10.1002/npr2.12456

BibTeX
@article{Tani2024,
  author = {Tani, Hideaki and Yonezawa, Kengo and Kusudo, Keisuke and Barrett, Frederick S and Nakajima, Shinichiro and Uchida, Hiroyuki},
  title = {Development of the Japanese version of the Challenging Experience Questionnaire},
  journal = {Neuropsychopharmacology Reports},
  year = {2024},
  doi = {10.1002/npr2.12456}
}
Kostenlos starten →